SGX Listed Stock

RAFFLES MEDICAL GROUP LTD (SGX:BSL)


SGD 1.110
+0.010 / +0.91%
Share Price as of: 2019-02-15 17:06
Market / ISIN Code: SGX Mainboard / SG1CH4000003
GICS® Sector / Industry Group / Industry: Health Care / Health Care Equipment & Services / Healthcare Providers and Services


Raffles Medical Blogger ArticlesRAFFLES MEDICAL GROUP LTD Blogger Articles SGX Listed RAFFLES MEDICAL GROUP LTD (SGX:BSL) Blogger Articles BSL.SI Blogger Articles
The Motley Fool Singapore
Jeremy Chia
2019-01-06 16:03:33
The Week in Numbers: Currency Flash Crash
In a shocking seven-minute spell on Thursday, the Japanese yen surged through levels it had held through almost a decade. During these seven minutes, the yen spiked 8% against the Australian dollar and 10% versus the Turkish Lira. With algorithmic trading commonplace, flash crashes have become more frequent. In 2016, the pound plunged 6% in two minutes. Earlier on Thursday, Apple Inc stunned investors when it cut its sales forecast for its latest quarter. The company forecast US$84 billion in revenue for its fiscal first quarter ended 29 December, below analysts estimate of US$91.5 billion. Apple had originally forecast revenue of between US$89 billion and US$93 billion. Apple CEO Tim Cook blamed slowing iPhone sales in China, whose economy has been hit by the uncertainty around the US-Chi
DollarsAndSense.sg
Max Chew
2019-01-06 09:37:02
4 Stocks This Week (Defensive Stocks) [4 January 2019] – M1; Raffles Medical; Sheng Siong; Wilmar
According to Investopedia, a defensive stock is a stock that is able to provide a consistent dividend and retain stable earnings regardless of the market condition. Due to a regular demand for their products and services, these stocks tend to remain relatively stable even during a market downturn. Conversely, they tend to underperform the market during times of economic expansion. For this week’s column, we feature 4 defensive stocks listed on SGX and how they fared for the past year. Read Also: How To Diversify Your Investment Portfolio Outside Of Singapore M1 Limited (SGX: B2F) M1 Limited is one of the major telecommunications companies providing mobile and fixed services to consumers and corporate customers in Singapore. As of 30 September 2018, M1 has around 1.36 million postpaid cus
The Motley Fool Singapore
Sudhan P.
2019-01-02 14:50:04
Raffles Medical Group Ltd Opens Its Chongqing Hospital
Raffles Medical Group Ltd (SGX: BSL) announced the opening of the much-awaited Raffles Hospital Chongqing before the stock market opened today. The hospital, which will be owned and operated by Raffles Medical, is Singapore’s first international tertiary hospital in China. What? Raffles Hospital Chongqing is a 700-bed hospital with two tower blocks connected by a three-storey podium, spanning over 100,000 square metres in gross floor area. The hospital will boast a hospital-hotel management style with suites, single, and two-bedded wards. When the hospital is fully opened, it will offer specialist services and centres of excellence in gastrointestinal surgery, obstetrics and gynaecology, paediatrics, cardiovascular surgery, neuroscience, and oncology. Raffles Hospital Chongqing’s medi
The Motley Fool Singapore
Jeremy Chia
2019-01-02 10:28:39
Why I Am Not Selling Raffles Medical Group Ltd Shares
Raffles Medical Group Ltd (SGX: BSL) was once a stock market darling.  From 2005 to 2015, the company was in its high-growth phase, expanding its network of clinics and hospital services. Raffles Medical Group’s revenue and profit grew alongside its expansion and expectations were high. However, in the past couple of years, the company’s growth has come to a halt, hurting the share price as a result. The big slowdown Stagnant revenue has led to suggestions that its core Singapore market has reached saturation. To compound the situation, the company also acquired a network of clinics overseas that has been loss-making, squeezing the company’s margins and profits. Not surprisingly, investors have “punished” Raffles Medical’s stock for its lack of growth. Fr
The Motley Fool Singapore
Chong Ser Jing
2018-12-26 11:28:32
The Hardest Thing About Investing
I was at my favourite book store browsing for interesting reads with a friend when we started talking about investing. She asked, “What exactly is value investing?” After I explained the concept – which in essence is buying a dollar for fifty cents – she commented: “It seems like the hardest part about investing is determining what the value of a company is.” Realisation That’s when it dawned on me: Not many may be aware that the hardest thing about investing isn’t learning how to interpret financial statements and work out the value of a company. The hardest thing is having the discipline to stay the course. You see, it’s one thing to know that patience and time is needed for an investment to work. It’s another thing to hold onto your shares when you’re d
The Motley Fool Singapore
Jeremy Chia
2018-12-20 12:32:26
2 Growth Shares in Singapore
When searching for high-growth companies for their portfolios, many local investors prefer to look overseas as there are a limited number of such companies in Singapore. However, that does not mean that there are simply no growth companies in Singapore to choose from. If we dig deep enough, we can sometimes find growth gems in the local stock market that could potentially make worthy investments. In this article, I will introduce two such stocks that I believe have a long runway for growth. The first company is MindChamps Preschool Ltd (SGX: CNE).  Most of us would have probably seen a MindChamps Preschool Centre somewhere around our neighbourhood. The company has been rapidly expanding its network of centres both locally and overseas, with a total of 17 company-owned and 54 franchisee-
Aspire
Don Low
2018-12-17 10:37:40
SI Research: Maintaining A Contrarian View Of Singapore Medical Group
Since the start of 2018, Singapore Medical Group has caught the attention of Shares Investment with its strong growth. However, despite another splendid quarter this earnings season, the stock continues to trail lower. At the time of writing, the stock of Singmedical had shed almost another 10 percent to trade at $0.40 per share, falling from $0.44 when we last reviewed the stock in August. Yet, amidst the negative share price performance, value seekers who believe that the long-term is a weighing machine should – in our view – continue accumulating or holding onto the stock. We reviewed the latest 3Q18 results and offer readers these reasons to maintain a contrarian view of the stock. Earnings Review Singmedical continues to be firing on all cylinders. For the latest quarter, revenue
The Motley Fool Singapore
Jeremy Chia
2018-12-13 11:23:38
2 Singapore-Listed Shares You Can Buy and Hold Forever
Warren Buffett once mentioned: “When we own portions of outstanding businesses with outstanding management, our favourite holding period is forever.” That said, finding stocks that you can potentially buy and hold forever is not easy. The company needs to have a long track record, have a competent management team, operate in resilient industries and have an established economic moat to shield it from competitors. In a small market like Singapore, it becomes even more challenging to find companies that exhibit all of these characteristics. However, despite my strict criteria, I believe I have found two stocks that potentially fit the bill. First on the list is DBS Group Holdings Ltd (SGX: D05), the largest bank in Singapore. When hunting for investments that can last a lifetime, it i
The Motley Fool Singapore
Jeremy Chia
2018-12-07 10:17:07
3 Things To Like About Raffles Medical Group Ltd’s 2018 Third-Quarter Results
At first glance,Raffles Medical Group Ltd (SGX: BSL) seems to have a pretty dull third quarter of 2018. Revenue only inched up 1.2% from a year ago and profit after tax was just 2.2% higher. On closer inspection, though, there are actually some good reasons to be optimistic about the company’s future. Positive updates on the opening of China hospitals Raffles Medical’s much-anticipated opening of two hospitals in China is on track. Raffles Hospital Chongqing is on track to open by the end of the year with procurement and construction progressing according to schedule. In addition, a team of both international and local physicians have already been recruited in anticipation of its opening. The construction of Raffles Hospital Shanghai is also progressing well, according to mana
The Motley Fool Singapore
Chong Ser Jing
2018-11-21 09:10:07
Sustainability Reports: A Step In The Right Direction
The sustainability report is probably one of the newer documents pioneered in recent years that public-listed companies have to produce. It also follows a shift in companies trying to establish good ESG (Environmental, Social, and Governance) practices. Singapore-listed companies are still slow in taking up this mantle, but there are companies that have begun to issue sustainability reports. As time goes by, I expect more to follow suit. In this article, I will be using Raffles Medical Group Ltd‘s (SGX: BSL) inaugural sustainability report – released on 15 November 2018 – to illustrate the typical features of such reports and what investors can look forward to from other companies in time to come. As an introduction, Raffles Medical Group is a leading integrated private h
The Motley Fool Singapore
Sudhan P.
2018-11-01 14:04:07
3 Shares to Help Pay for Your Child’s University Education
Saving for our children’s university education can be a huge financial commitment. A four-year undergraduate program in Singapore’s public universities costs an average of S$40,000 for local students. The figure, which excludes other miscellaneous fees, is around a third more than a decade ago. With inflation, the fees will only increase in the coming years. Although there are a myriad of options to save up for your child’s tertiary education, investing in shares might be the best of them all. With a time horizon of some 20 years before a newborn hits university-age, putting money in the stock market for the very long-term becomes almost risk-free. With that, here are three shares that you can consider investing in to pay for your precious one’s university education. Company #1
The Motley Fool Singapore
Lawrence Nga
2018-10-31 09:32:22
The Good And Bad That Investors Should Know About Raffles Medical Group Ltd’s Latest Results
Raffles Medical Group Ltd (SGX: BSL) runs hospital and healthcare services in Singapore. It also has a network of clinics in five countries and thirteen cities. Furthermore, it has two hospitals under development in China. The company recently reported its 2018 third quarter (3Q FY18) earnings update. In this article, I will look at the positive and not-so-positive aspects of its update. The positives First of all, Raffles Medical achieved higher revenue and net profit for the quarter. The former was up by 1.2% year-on-year to S$121.0 million while the latter grew 2.2% year-on-year to S$16.2 million. Healthcare Services division grew revenue by 8.0% year-on-year due to the addition of new corporate clients and the new contract to provide Air Borders screening services. Secondly, the comp
The Motley Fool Singapore
Lawrence Nga
2018-10-30 12:19:08
10 Quick Things That Investors Should Know About Raffles Medical Group Ltd’s Latest Results
On Monday, Raffles Medical Group Ltd (SGX: BSL) announced its 2018 third quarter (3Q FY18) earnings update. As a quick introduction, Raffles Medical runs hospital and healthcare services in Singapore. It also has a network of clinics in five countries and thirteen cities. Furthermore, it has two hospitals under development in China. Here, let’s look at 10 things that investors should know from its latest earnings update: 1. Revenue for the quarter improved 1.2% year-on-year to S$121.0 million. 2. Operating profit climbed 4.5% year-on-year to S$19.2 million. 3. EBITDA (earnings before interest tax depreciation and amortisation) grew 8.5% to S$23.9 million. 4. Similarly, net profit grew 2.2% year-on-year to S$16.2 million. 5. Diluted earnings per share (EPS) was down by 1.1% year-on-ye
The Motley Fool Singapore
Lawrence Nga
2018-10-23 10:38:35
A Better Healthcare Stock To Buy: Raffles Medical Group Ltd Vs. Singapore O&G Ltd (Part 2)
Healthcare companies are generally considered as defensive stocks since their services are needed when the economy’s good as well as bad. The defensive nature of their businesses also makes healthcare companies attractive to investors. There are many healthcare companies in Singapore’s stock market and you might want to know which is a better investment opportunity. There’s no easy answer, but I want to directly compare the important business and valuation aspects of two healthcare services providers – Raffles Medical Group Ltd (SGX: BSL) and Singapore O&G Ltd  (SGX: 1D8) – in a mini article-series. This article is the second in the series and it compares the long term track record of growth for the two companies; the objective is to find out which of the duo did a
The Motley Fool Singapore
Lawrence Nga
2018-10-23 10:36:57
A Better Healthcare Stock To Buy: Raffles Medical Group Ltd Vs. Singapore O&G Ltd (Part 3)
Healthcare companies are generally considered as defensive stocks since their services are needed when the economy’s good as well as bad. The defensive nature of their businesses also makes healthcare companies attractive to investors. There are many healthcare companies in Singapore’s stock market and you might want to know which is a better investment opportunity. There’s no easy answer, but I want to directly compare the important business and valuation aspects of two healthcare services providers – Raffles Medical Group Ltd (SGX: BSL) and Singapore O&G Ltd  (SGX: 1D8) – in a mini article-series. This article is the third and last in the series and it compares the valuations of the two healthcare companies. In particular, the valuation metrics I will focus on are the
DollarsAndSense.sg
Timothy Ho
2018-10-22 11:58:22
3 Important Things To Understand About Raffles Health Insurance Shield Plan Before Buying It
Earlier this year, Raffles Health Insurance, a fully-owned subsidiary of Raffles Medical Group, announced the launch of Raffles Shield. Raffles Shield is the seventh private integrated shield plan to be launched in Singapore. While Raffles Shield isn’t the first entrant into the market, it’s noteworthy to know that it’s the first (and only) private integrated shield plan to be launched and backed by an insurer which is actually part of a medical group, rather than a traditional insurer. Read Also: Singapore’s Medical Inflation Rate Is At 15%: Why That Spells Disaster For Us Beyond just being a product launched and backed by a medical group, it’s also important for anyone considering the purchase of Raffles Shield to know about some of the unique features that the plan is offering
The Fifth Person
Adam Wong
2018-10-19 18:25:42
5 things to know before you invest in the Phillip SING Income ETF
A year ago, Phillip Capital Management, along with Lion Global Investors, launched the Lion-Phillip S-REIT ETF. The ETF aimed to give investors a way to invest in a diversified basket of Singapore REITs (S-REITs) which paid a steady stream of distributions. (At the moment, the average distribution yield for S-REITs is 6.8%.) The ETF was met with a largely positive response from the market – Lion Global Investors and Phillip Capital Management initially aimed to raise S$40-50 million but exceeded their target when the fund raised over S$100 million last October. Capitalizing on the Singapore market’s appetite for yield, Phillip Capital Management has now launched the Phillip SING Income ETF. The initial offer period for the ETF will close at 11:00 a.m. on 19 October 2018 before its list
The Motley Fool Singapore
Lawrence Nga
2018-10-19 08:13:53
A Better Healthcare Stock To Buy: Raffles Medical Group Ltd Vs. Singapore O&G Ltd (Part 1)
Healthcare companies are generally considered as defensive stocks since their services are needed when the economy’s good as well as bad. The defensive nature of their businesses also makes healthcare companies attractive to investors. There are many healthcare companies in Singapore’s stock market and you might want to know which is a better investment opportunity. There’s no easy answer, but I want to directly compare the important business and valuation aspects of two healthcare services providers – Raffles Medical Group Ltd (SGX: BSL) and Singapore O&G Ltd  (SGX: 1D8) – in a mini article-series. This article is the first in the series and it compares the most recent quarterly earnings updates of the two companies. The objective is to find out which compa
Ernest Lim's Investing Blog
el15
2018-10-03 19:23:11
Sing Medical trades near one year low despite a 70% jump in 1HFY18 net profit! (3 Oct 2018)
This week, Sing Medical (“SMG”) caught my attention. SMG has dropped 39% from $0.725 on 18 Jul 2017 to trade $0.440 on 3 Oct 2018. My personal guess is part of the fall may be attributable to a) Lower, or no earnings growth for some of the healthcare players in FY18F. However, this is likely not the case for SMG, as analysts believe SMG is on track for a minimum 40% growth in FY18F net profit. It is noteworthy that SMG already posted a 70% jump in 1HFY18 net profit; b) Reduction in the general PE valuations ascribed to the healthcare sector;   So, what caught my attention? a) Positive chart: SMG is testing its downtrend line established since 26 Jan 2018 (See Chart 1 below). Indicators such as OBV, RSI and MACD are strengthening. ADX has started to rise and last trades 22.6 on 3 Oct 2





Investment BloggerSG Investment BlogSG Invest BloggersBloggers Say








Your Say











Stock / REIT Search

Advertisement

Advertisement